000			06611cam a2200469Ia 4500
988			_aSpringer_Medicine_2017
999			_c96454 _d96454 _x1
001			96454
003			ES-MaUEC
005			20230102112754.0
006			m o d
007			cr |n|||||||||
008			170830s2017 nyu ob 001 0 eng d
020			_a3319571532 _q(electronic bk.)
020			_a9783319571539 _q(electronic bk.)
020			_z3319571524
020			_z9783319571522
040			_aYDX _beng _cYDX _dN$T _dEBLCP _dGW5XE _dN$T _dUAB _dOCLCF _dMERER _dYDX _dOCLCQ _dESU _dIOG _dCOO _dDEBBG _dOCLCO _dOCLCA _dNJR _dES-MaUEC _bspa
050		4	_aRM301.37 _b2017 EB
066			_c(S
245	0	0	_aCell therapy : _bcurrent status and future directions _cDwaine F. Emerich, Gorka Orive, editors.
264		1	_aNew York, NY _bHumana Press _c2017
300			_a1 recurso en línea
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
490	0		_aMolecular and translational medicine _x2197-7852
500			_a
504			_aIncluye referencias bibliográficas e índice
505	0		_aDedication; Preface: A Brief Introduction to the Span of Cell Therapy; Contents; Contributors; 1: Molecular Considerations in Cell Transplant Imaging; Introduction; The Need for Molecular Imaging: Limitations of Cell-Based Therapies;Recent Advances in Molecular Imaging;Bright-Field and Fluorescent Optical Imaging; PET Imaging; Bioluminescence Imaging; MR Imaging and Spectroscopy; Concluding Remarks and Outlook; References; 2: Considerations for Successful Encapsulated B-cell Therapy; Introduction; Islet Transplantation; Islet Transplantation: Site Selection Considerations
505	8		_aEncapsulating Islets: Biomass Considerations Islet Encapsulation Failure Modes;Subacute Processing Stress; Acute Implant Failure; Chronic Failure of Cell Encapsulation Systems; Immune Rejection; Hypoxia; Strategies for Addressing Hypoxia; Refillable Gas Supply; Artificial Oxygen Carriers; Vascularization; Strategies for Mitigating Chronic Fibrosis; Coatings and Covalent Modifications; Stem Cell-Derived B-Cells as an Alternative to Isolated Cadaveric Islets; Generation of Glucoresponsive Stem Cell-Derived B-Cells; Clinical Translation of Stem Cell-Derived B-Cells
505	8		_aIncreased Inhibition Strategies Limits of This Approach; Cell Therapy: Encapsulated Cell Biodelivery (ECB) Systems; Introduction: Description of the Strategy; Increased Inhibition Strategies: Galanin; Neurotrophic Factors; Delivering NTF with ECB Devices; References; 6: Dendritic Cell-Based Cancer Therapies: Current Status and Future Directions; Introduction; Dendritic Cell Subpopulations; Plasmacytoid Dendritic Cells; Conventional/Myeloid Dendritic Cells; Skin Dendritic Cells; Inflammatory DCs; Dendritic Cell Functions; Activating Signals from DCs; Inhibitory Signals from DCs
505	8		_aTBI and Stroke: Implications of Cell-Free Treatment Feasibility of Exosome Transplantation Therapies; Conclusion: Connecting the Dots of Stem Cell Therapy; References; 4: Cell Replacement Strategies for Parkinson's Disease; Introduction; Ventral Mesencephalon Grafting; Clinical Trial Outcomes; Stem Cell Grafting; Conclusions; References; 5: Cell Therapy for Epilepsy; Epilepsy; History; Definitions, Clinical Features, Therapeutic Needs, and Models; Cell Therapy: Direct Grafting; Introduction: Cell Types; Substitution Strategies and Bystander Effects
505	8		_aThe Future of B-Cell TherapyReferences; 3: Stem Cell Therapy for Neurovascular and Traumatic Brain Diseases; Introduction; Acute Pathology of Stroke and TBI; Chronic Pathology of Stroke and TBI; Stem Cell Therapy for Neurovascular Disorders; Stem Cell Transplantation in Stroke; Stem Cell Transplantation in TBI; Mechanisms of Stem Cell Therapy; The Promise of Combination Therapies with Stem Cells; The Spleen as a Novel Target for Stem Cells; Challenges in Stem Cell Therapy; Potential Adverse Effects of Stem Cell Therapy; Cell-Free Materials and Exosomes in Neurovascular Therapy
520	3		_aThis volume provides a comprehensive, state-of-the art review of the field of cell therapy. The volume begins with an overview of the breadth of the field and then turns to overviews of imaging technologies that can aid in both safety and efficacy evaluations. The book then turns to numerous contributions detailing the rapidly growing field of stem cell therapies. These sections cover our understanding of the natural roles of stem cells in biology and human disease and then touches on several of the more prominent areas where stem cells are moving rapidly into clinical evaluation including neurodegenerative diseases, muscular dystrophy, cardiac repair, and diabetes. The volume concludes with contributions from experts in oncology, ophthalmiology, stem cells, 3-D printing, and biomaterials where the convergence of expertise is leading to unprecedented insights into how to minutely control the in vivo fate and function of transplanted and/or endogeneously mobilized cells. Finally, the book provides insights into the pivotal relationship between academic and industrial partnerships. This volume is designed to touch on the major areas where the field will make its greatest and most immediate clinical impacts. This text will provide a useful resource for physicians and researchers interested in the rapidly changing filed of cell therapy.
650		7	_aDrogas _xEfectos fisiológicos _2embne _0(OCoLC)fst00850322 _9169030
700	1		_aEmerich, Dwaine F.
700	1		_aOrive, Gorka.
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-3-319-57153-9 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
880	0		_6505-00 _aMolecular Considerations in Cell Transplant Imaging -- Considerations for Successful Encapsulated β Cell Therapy -- Stem Cell Therapy for Neurovascular and Traumatic Brain Diseases -- Cell Replacement Strategies for Parkinson's Disease -- Cell Therapy for Epilepsy -- Dendritic Cell-Based Cancer Therapies: Current Status and Future Directions -- Encapsulation Approaches to Cell Therapy -- Biomaterials and Cells for Re-Vascularization -- Cell Reprogramming for Cardiac Regeneration and Rare Disease Modeling -- Engineering Organoid Systems to Model Health and Disease -- 3D Printing for Cell Therapy Applications -- Cell Therapy for Ophthalmic Diseases -- Cell Therapy: Approaching a Partnership with Pharma -- Stem Cell Therapy in Duchenne Muscular Dystrophy.
942			_2lcc _cLE
998			_b02/2018 _dz _e- _zSI